Litcius/Paper detail

Prognostic value of the neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio and systemic immune‐inflammation index in patients with laryngeal squamous cell carcinoma

Zhilin Li, Yi Qu, Yang Yang, Wei An, Yan Li, Bin Wang, Ying He, Jing Li, Qi Shao, Lizheng Qin

2020Clinical Otolaryngology33 citationsDOI

Abstract

OBJECTIVES: We aimed to determine the prognostic value of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) in patients with laryngeal squamous cell carcinoma (LSCC). DESIGN AND SETTING: A retrospective analysis of patients with LSCC was conducted in our hospitals. Clinical information, including age, sex, TNM classification and other demographic and clinical data, was acquired and analysed. Progression-free survival (PFS) and overall survival (OS) were calculated and compared using the Kaplan-Meier method and log-rank test. PARTICIPANTS: A total of 147 patients with LSCC were included. RESULTS: According to the receiver operating characteristic (ROC) curve, the optimal cut-off points for NLR, PLR and SII were 1.88, 117.36 and 517.64. The analysis revealed NLR, PLR and SII to be independent predictors for OS and PFS (P < .05). CONCLUSIONS: Preoperative NLR, PLR and SII are promising prognostic predictors for patients with LSCC.

Topics & Concepts

MedicineInternal medicineReceiver operating characteristicNeutrophil to lymphocyte ratioLymphocyteGastroenterologyRetrospective cohort studyImmune systemOncologySystemic inflammationInflammationImmunologyInflammatory Biomarkers in Disease PrognosisHead and Neck Cancer StudiesCancer Immunotherapy and Biomarkers
Prognostic value of the neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio and systemic immune‐inflammation index in patients with laryngeal squamous cell carcinoma | Litcius